The global market for Mobile ECG Telemetry Device was valued at US$ 1237 million in the year 2024 and is projected to reach a revised size of US$ 2639 million by 2031, growing at a CAGR of 11.6% during the forecast period.
Mobile ECG telemetry equipment is an ECG diagnostic medical device that performs radio telemetry on human bioelectricity. It is easy to use and simple to operate, and realizes the measurement, monitoring, condition observation and data analysis of the vital signs of mobile patients.
North American market for Mobile ECG Telemetry Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mobile ECG Telemetry Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mobile ECG Telemetry Device include Applied Cardiac Systems Inc., Biotricity Inc., Medtronic plc, Preventice Solutions, Inc., Boston Scientific Corporation, BioTelemetry Inc., National Cardiac Inc., Telerhythmics LLC, The ScottCare Corporation, Medicomp Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mobile ECG Telemetry Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mobile ECG Telemetry Device.
The Mobile ECG Telemetry Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mobile ECG Telemetry Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mobile ECG Telemetry Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Applied Cardiac Systems Inc.
Biotricity Inc.
Medtronic plc
Preventice Solutions, Inc.
Boston Scientific Corporation
BioTelemetry Inc.
National Cardiac Inc.
Telerhythmics LLC
The ScottCare Corporation
Medicomp Inc.
GE Healthcare
Philips Healthcare
Hemodynamics Company
Lifewatch
MidMark
Baxter
Spacelabs
Wuhan Mingde Biotechnology Co., Ltd.
Segment by Type
Wearable
Electronic SMD
Segment by Application
Hospital
Personal
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mobile ECG Telemetry Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mobile ECG Telemetry Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Mobile ECG Telemetry Device Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 Mobile ECG Telemetry Device by Type
1.2.1 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 Wearable
1.2.3 Electronic SMD
1.3 Mobile ECG Telemetry Device by Application
1.3.1 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Personal
1.3.4 Other
1.4 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Mobile ECG Telemetry Device Revenue 2020-2031
1.4.2 Global Mobile ECG Telemetry Device Sales 2020-2031
1.4.3 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mobile ECG Telemetry Device Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Mobile ECG Telemetry Device Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global Mobile ECG Telemetry Device Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global Mobile ECG Telemetry Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mobile ECG Telemetry Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mobile ECG Telemetry Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mobile ECG Telemetry Device, Product Type & Application
2.7 Global Key Manufacturers of Mobile ECG Telemetry Device, Date of Enter into This Industry
2.8 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest Mobile ECG Telemetry Device Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Scenario by Region
3.1 Global Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mobile ECG Telemetry Device Sales by Region: 2020-2031
3.2.1 Global Mobile ECG Telemetry Device Sales by Region: 2020-2025
3.2.2 Global Mobile ECG Telemetry Device Sales by Region: 2026-2031
3.3 Global Mobile ECG Telemetry Device Revenue by Region: 2020-2031
3.3.1 Global Mobile ECG Telemetry Device Revenue by Region: 2020-2025
3.3.2 Global Mobile ECG Telemetry Device Revenue by Region: 2026-2031
3.4 North America Mobile ECG Telemetry Device Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mobile ECG Telemetry Device Sales by Country (2020-2031)
3.4.3 North America Mobile ECG Telemetry Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mobile ECG Telemetry Device Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mobile ECG Telemetry Device Sales by Country (2020-2031)
3.5.3 Europe Mobile ECG Telemetry Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mobile ECG Telemetry Device Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mobile ECG Telemetry Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Mobile ECG Telemetry Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mobile ECG Telemetry Device Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mobile ECG Telemetry Device Sales by Country (2020-2031)
3.7.3 Latin America Mobile ECG Telemetry Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mobile ECG Telemetry Device Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Mobile ECG Telemetry Device Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mobile ECG Telemetry Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mobile ECG Telemetry Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mobile ECG Telemetry Device Sales by Type (2020-2031)
4.1.1 Global Mobile ECG Telemetry Device Sales by Type (2020-2025)
4.1.2 Global Mobile ECG Telemetry Device Sales by Type (2026-2031)
4.1.3 Global Mobile ECG Telemetry Device Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global Mobile ECG Telemetry Device Revenue by Type (2020-2031)
4.2.1 Global Mobile ECG Telemetry Device Revenue by Type (2020-2025)
4.2.2 Global Mobile ECG Telemetry Device Revenue by Type (2026-2031)
4.2.3 Global Mobile ECG Telemetry Device Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global Mobile ECG Telemetry Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mobile ECG Telemetry Device Sales by Application (2020-2031)
5.1.1 Global Mobile ECG Telemetry Device Sales by Application (2020-2025)
5.1.2 Global Mobile ECG Telemetry Device Sales by Application (2026-2031)
5.1.3 Global Mobile ECG Telemetry Device Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global Mobile ECG Telemetry Device Revenue by Application (2020-2031)
5.2.1 Global Mobile ECG Telemetry Device Revenue by Application (2020-2025)
5.2.2 Global Mobile ECG Telemetry Device Revenue by Application (2026-2031)
5.2.3 Global Mobile ECG Telemetry Device Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global Mobile ECG Telemetry Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Applied Cardiac Systems Inc.
6.1.1 Applied Cardiac Systems Inc. Company Information
6.1.2 Applied Cardiac Systems Inc. Description and Business Overview
6.1.3 Applied Cardiac Systems Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Applied Cardiac Systems Inc. Mobile ECG Telemetry Device Product Portfolio
6.1.5 Applied Cardiac Systems Inc. Recent Developments/Updates
6.2 Biotricity Inc.
6.2.1 Biotricity Inc. Company Information
6.2.2 Biotricity Inc. Description and Business Overview
6.2.3 Biotricity Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Biotricity Inc. Mobile ECG Telemetry Device Product Portfolio
6.2.5 Biotricity Inc. Recent Developments/Updates
6.3 Medtronic plc
6.3.1 Medtronic plc Company Information
6.3.2 Medtronic plc Description and Business Overview
6.3.3 Medtronic plc Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic plc Mobile ECG Telemetry Device Product Portfolio
6.3.5 Medtronic plc Recent Developments/Updates
6.4 Preventice Solutions, Inc.
6.4.1 Preventice Solutions, Inc. Company Information
6.4.2 Preventice Solutions, Inc. Description and Business Overview
6.4.3 Preventice Solutions, Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Preventice Solutions, Inc. Mobile ECG Telemetry Device Product Portfolio
6.4.5 Preventice Solutions, Inc. Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Company Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Corporation Mobile ECG Telemetry Device Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 BioTelemetry Inc.
6.6.1 BioTelemetry Inc. Company Information
6.6.2 BioTelemetry Inc. Description and Business Overview
6.6.3 BioTelemetry Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioTelemetry Inc. Mobile ECG Telemetry Device Product Portfolio
6.6.5 BioTelemetry Inc. Recent Developments/Updates
6.7 National Cardiac Inc.
6.7.1 National Cardiac Inc. Company Information
6.7.2 National Cardiac Inc. Description and Business Overview
6.7.3 National Cardiac Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 National Cardiac Inc. Mobile ECG Telemetry Device Product Portfolio
6.7.5 National Cardiac Inc. Recent Developments/Updates
6.8 Telerhythmics LLC
6.8.1 Telerhythmics LLC Company Information
6.8.2 Telerhythmics LLC Description and Business Overview
6.8.3 Telerhythmics LLC Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Telerhythmics LLC Mobile ECG Telemetry Device Product Portfolio
6.8.5 Telerhythmics LLC Recent Developments/Updates
6.9 The ScottCare Corporation
6.9.1 The ScottCare Corporation Company Information
6.9.2 The ScottCare Corporation Description and Business Overview
6.9.3 The ScottCare Corporation Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 The ScottCare Corporation Mobile ECG Telemetry Device Product Portfolio
6.9.5 The ScottCare Corporation Recent Developments/Updates
6.10 Medicomp Inc.
6.10.1 Medicomp Inc. Company Information
6.10.2 Medicomp Inc. Description and Business Overview
6.10.3 Medicomp Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Medicomp Inc. Mobile ECG Telemetry Device Product Portfolio
6.10.5 Medicomp Inc. Recent Developments/Updates
6.11 GE Healthcare
6.11.1 GE Healthcare Company Information
6.11.2 GE Healthcare Description and Business Overview
6.11.3 GE Healthcare Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GE Healthcare Mobile ECG Telemetry Device Product Portfolio
6.11.5 GE Healthcare Recent Developments/Updates
6.12 Philips Healthcare
6.12.1 Philips Healthcare Company Information
6.12.2 Philips Healthcare Description and Business Overview
6.12.3 Philips Healthcare Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Philips Healthcare Mobile ECG Telemetry Device Product Portfolio
6.12.5 Philips Healthcare Recent Developments/Updates
6.13 Hemodynamics Company
6.13.1 Hemodynamics Company Company Information
6.13.2 Hemodynamics Company Description and Business Overview
6.13.3 Hemodynamics Company Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hemodynamics Company Mobile ECG Telemetry Device Product Portfolio
6.13.5 Hemodynamics Company Recent Developments/Updates
6.14 Lifewatch
6.14.1 Lifewatch Company Information
6.14.2 Lifewatch Description and Business Overview
6.14.3 Lifewatch Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lifewatch Mobile ECG Telemetry Device Product Portfolio
6.14.5 Lifewatch Recent Developments/Updates
6.15 MidMark
6.15.1 MidMark Company Information
6.15.2 MidMark Description and Business Overview
6.15.3 MidMark Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 MidMark Mobile ECG Telemetry Device Product Portfolio
6.15.5 MidMark Recent Developments/Updates
6.16 Baxter
6.16.1 Baxter Company Information
6.16.2 Baxter Description and Business Overview
6.16.3 Baxter Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Baxter Mobile ECG Telemetry Device Product Portfolio
6.16.5 Baxter Recent Developments/Updates
6.17 Spacelabs
6.17.1 Spacelabs Company Information
6.17.2 Spacelabs Description and Business Overview
6.17.3 Spacelabs Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Spacelabs Mobile ECG Telemetry Device Product Portfolio
6.17.5 Spacelabs Recent Developments/Updates
6.18 Wuhan Mingde Biotechnology Co., Ltd.
6.18.1 Wuhan Mingde Biotechnology Co., Ltd. Company Information
6.18.2 Wuhan Mingde Biotechnology Co., Ltd. Description and Business Overview
6.18.3 Wuhan Mingde Biotechnology Co., Ltd. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Wuhan Mingde Biotechnology Co., Ltd. Mobile ECG Telemetry Device Product Portfolio
6.18.5 Wuhan Mingde Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mobile ECG Telemetry Device Industry Chain Analysis
7.2 Mobile ECG Telemetry Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mobile ECG Telemetry Device Production Mode & Process Analysis
7.4 Mobile ECG Telemetry Device Sales and Âé¶¹Ô´´ing
7.4.1 Mobile ECG Telemetry Device Sales Channels
7.4.2 Mobile ECG Telemetry Device Distributors
7.5 Mobile ECG Telemetry Device Customer Analysis
8 Mobile ECG Telemetry Device Âé¶¹Ô´´ Dynamics
8.1 Mobile ECG Telemetry Device Industry Trends
8.2 Mobile ECG Telemetry Device Âé¶¹Ô´´ Drivers
8.3 Mobile ECG Telemetry Device Âé¶¹Ô´´ Challenges
8.4 Mobile ECG Telemetry Device Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Applied Cardiac Systems Inc.
Biotricity Inc.
Medtronic plc
Preventice Solutions, Inc.
Boston Scientific Corporation
BioTelemetry Inc.
National Cardiac Inc.
Telerhythmics LLC
The ScottCare Corporation
Medicomp Inc.
GE Healthcare
Philips Healthcare
Hemodynamics Company
Lifewatch
MidMark
Baxter
Spacelabs
Wuhan Mingde Biotechnology Co., Ltd.
Ìý
Ìý
*If Applicable.